Free Trial

Novo Nordisk A/S (NVO) Insider Trading & Ownership

Novo Nordisk A/S logo
$69.08 -0.15 (-0.22%)
Closing price 03:59 PM Eastern
Extended Trading
$69.29 +0.21 (+0.30%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

There is no recent insider trading on record for Novo Nordisk A/S, but the stock has been recently traded by U.S. Congress members, who may have more information about the industry than the general public.

Get NVO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Novo Nordisk A/S stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Novo Nordisk A/S Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellAverage Share PriceTotal Transaction
3/27/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$70.18$1,001 - $15,000
3/27/2025C. Scott FranklinU.S. Congress Member (R-FL)Buy$70.18$15,001 - $50,000
3/20/2025Byron DonaldsU.S. Congress Member (R-FL)Sell$78.73$1,001 - $15,000
9/4/2024John JamesU.S. Congress Member (R-MI)Sell$134.50$1,001 - $15,000
1/19/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$106.95$15,001 - $50,000
7/12/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$38.69$100,001 - $250,000
7/10/2023Daniel S. GoldmanU.S. Congress Member (D-NY)Sell$39.27$250,001 - $500,000
(Data available from 1/1/2013 forward)

NVO Insider Trading Activity - Frequently Asked Questions

0.07% of Novo Nordisk A/S stock is owned by insiders. Learn more on NVO's insider holdings.

C. Scott Franklin (R-FL) has bought shares of Novo Nordisk A/S in the last year totaling $40,500. Byron Donalds (R-FL) and John James (R-MI) have sold shares totaling $16,000.

Novo Nordisk A/S Key Executives



This page (NYSE:NVO) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners